Active [ftcn]
Immunization, Passive [topp]
respiratory syncytial virus RSV [virs]
respiratory [ftcn]
Illness [fndg]
Infants [aggp]
Age [orga]
Respiratory infection [dsyn]
Adults [aggp]
Elderly [popg]
Immunocompromised [fndg]
Active [ftcn]
interventions [hlca]
IMPACT [gngm]
rsv infection [dsyn]
lack [qlco]
Understanding [menp]
Immune response [ortf]
Age Groups [aggp]
strategies [menp]
RSV Vaccines [imft, phsu]
Including [ftcn]
live vaccines [imft, phsu]
Attenuated [qlco]
engineered [prog]
Live [qlco]
Vaccines, Subunit [imft, phsu]
Vaccines, Peptide [imft, phsu]
degrees [qnco]
Success [socb]
Target Population [popg]
RSV Vaccines [imft, phsu]
Infants [aggp]
Elderly [popg]
Women [popg]
Age [orga]
Efficacy [qlco]
Vaccines [imft, phsu]
Age [orga]
immune responses [ortf]
Immune [ftcn]
Protection [fndg]
Humans [humn]
Uncertain [idcn]
Critical [qlco]
Introduction [hlca]
Vaccines [imft, phsu]
prophylaxis [inpr]
treatment [ftcn]
Infants [aggp]
Human immunoglobulin [aapp, imft, phsu]
Containing [ftcn]
Titre [qnco]
Specific antibody [aapp, imft]
Ig [aapp, imft, phsu]
Limited [ftcn]
Success [socb]
Infant [aggp]
prophylaxis [inpr]
Premature Infants [aggp]
Ig [aapp, imft, phsu]
Bronchopulmonary Dysplasia [dsyn]
Limited [ftcn]
Efficacy [qlco]
Contrast [qlco]
Safety [hcpp]
Concern [idcn]
Preparation [ftcn]
prophylaxis [inpr]
Infants [aggp]
Congenital heart disease [cgab, dsyn]
Demonstrable [ftcn]
Efficacy [qlco]
In [qnco]
treatment [ftcn]
health infants [hlca]
Cost [qnco]
Preparation [ftcn]
limit [ftcn]
Highly [qlco]
Select [acty]
Infant [aggp]
Group [idcn]
production [ocac]
Monoclonal Antibodies [aapp, imft]
Immunotherapy, Passive [topp]
intervention [hlca]
increased activity [fndg]
Specific [qlco]
Reduced [qlco]
side effects [ftcn]
Experimental [qlco]
Copyright [inpr]
Son [famg]
LTD [ortf]
